These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34354193)

  • 1. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Kato K; Abe H; Ono H; Kawano T; Yoshida Y; Tanabe T; Okubo T; Hayama K; Nakagawa-Iwashita A; Itokawa N; Kondo C; Kaneko K; Emoto N; Nagao M; Inagaki K; Fukuda I; Sugihara H; Iwakiri K
    Sci Rep; 2021 Aug; 11(1):15938. PubMed ID: 34354193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Kawano T; Koeda M; Yoshida Y; Tanabe T; Okubo T; Hayama K; Iwashita A; Itokawa N; Kondo C; Kaneko K; Kawamoto C; Hatori T; Emoto N; Iio E; Tanaka Y; Iwakiri K
    PLoS One; 2019; 14(11):e0224184. PubMed ID: 31721770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men.
    Durak H; Çetin M; Emlek N; Özyıldız AG; Ergül E; Duman H
    Int J Cardiovasc Imaging; 2024 Sep; 40(9):1979-1986. PubMed ID: 39012403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
    Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
    Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
    Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum.
    León-Mengíbar J; Sánchez E; Herrerías F; De La Fuente MC; Santamaría M; Valdivielso JM; Bermúdez-López M; Castro E; Pallarés J; Matias-Guiu X; Vilardell F; Caixàs A; Bueno M; Martí R; Lecube A
    Front Endocrinol (Lausanne); 2024; 15():1366015. PubMed ID: 38774226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease.
    Yari FA; Shabani P; Karami S; Sarmadi N; Poustchi H; Bandegi AR
    BMC Endocr Disord; 2021 Aug; 21(1):153. PubMed ID: 34344333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Nadinskaia M; Maevskaya M; Ivashkin V; Kodzoeva K; Pirogova I; Chesnokov E; Nersesov A; Kaibullayeva J; Konysbekova A; Raissova A; Khamrabaeva F; Zueva E
    World J Gastroenterol; 2021 Mar; 27(10):959-975. PubMed ID: 33776366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.
    Dogan T; Ozturk K; Celikkanat S; Aykan MB; Uygun A
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1460-1466. PubMed ID: 31045630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD.
    Shabbirhussain BV; Singh S; Dixit VK; Verma A; Singh SK
    Diabetes Metab Syndr; 2022 Jul; 16(7):102560. PubMed ID: 35816948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Sladoje-Martinovic B; Orlic L
    Kidney Blood Press Res; 2014; 39(4):308-14. PubMed ID: 25300437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis.
    Sagar A; L R; Farheen SA
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.